ProQR spins out Amylon Therapeutics

ProQR spins out Amylon Therapeutics as a privately-held company focused on central nervous system (CNS) therapeutics Key updates ProQR spins out CNS-focused company, Amylon Therapeutics, with seed funding from a group of institutional and private investors. As part of...